SCHEMBL4018595

SCHEMBL4018595

C=CCCCC(CCCC=C)(C(=O)OCC)C(=O)OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 4/20 0.41
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CYP4F2 P78329 2/20 0.41
CYP4A11 Q02928 2/20 0.41
PKM P14618 2/20 0.41
THRB P10828 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
HTT P42858 1/20 0.40
TSHR P16473 2/20 0.38
MAPT P10636 4/20 0.37
ATM Q13315 1/20 0.37
ABCC4 O15439 1/20 0.35
HCAR2 Q8TDS4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31437002 0.91 MEN1 (0.42) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL15074624 0.91 MEN1 (0.42) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL7758971 0.90 MEN1 (0.52) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL14567210 0.88 MEN1 (0.40) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL11087650 0.88 ALDH1A1 (0.43) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL13253975 0.87 CYP4F2 (0.43) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL7236425 0.85 LMNA (0.40) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL5352192 0.85 MEN1 (0.39) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL5353749 0.84 LMNA (0.39) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL6936029 0.84 LMNA (0.39) MEN1KMT2AALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260007786-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES SPAGO NANOMEDICAL AB (SE) 2026-01-08 US disclosed
EP-4490218-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES Spago Nanomedical AB (SE) 2025-01-15 EP disclosed
WO-2023172185-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES SPAGO NANOMEDICAL AB (SE) 2023-09-14 WO disclosed
EP-4242250-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES Spago Nanomedical AB (SE) 2023-09-13 EP disclosed
US-7504465-B2 Linear functional copolymers of ethylene with precise and minimum run length distributions and methods of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2009-03-17 US disclosed
US-20080312393-A1 Linear functional copolymers of ethylene with precise and minimum run length distributions and methods of making thereof BAUGH LISA S 2008-12-18 US disclosed
US-7402642-B2 Linear functional copolymers of ethylene with precise and minimum run length distributions and method of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2008-07-22 US disclosed
EP-1704172-A1 LINEAR FUNCTIONAL COPOLYMERS OF ETHYLENE WITH PRECISE AND MINIMUM RUN LENGTH DISTRIBUTIONS AND METHODS OF MAKING THEREOF ExxonMobil Research and Engineering Company (US) 2006-09-27 EP disclosed
WO-2005063834-A1 LINEAR FUNCTIONAL COPOLYMERS OF ETHYLENE WITH PRECISE AND MINIMUM RUN LENGTH DISTRIBUTIONS AND METHODS OF MAKING THEREOF EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2005-07-14 WO disclosed
US-20050137369-A1 Linear functional copolymers of ethylene with precise and minimum run length distributions and method of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260007786-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES SCO2, PYM1, SSB MEN1 299/4885KMT2A 1233/4885ALDH1A1 4535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.